{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:45:43Z","timestamp":1760150743606,"version":"build-2065373602"},"reference-count":52,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Currently, over 200,000 new cases of leprosy are reported annually worldwide. Although leprosy was thought to have been eradicated in Taiwan, a few new cases still occur annually. Protean clinical manifestations of leprosy and immunological reactions result in delayed diagnoses. In addition, drug-resistant leprosy is emerging and poses treatment challenges. In this retrospective study, we collected and analyzed the clinicopathological features, leprosy type, treatment response, and relapse rate of patients with leprosy in our hospital between January 2009 and November 2022. We found that 54% of patients were Indonesian, and borderline lepromatous leprosy was predominant (39%); moreover, histoid leprosy and the Lucio phenomenon were also reported. Polymerase chain reaction analysis identified four positive cases, including a dapsone-resistant (4%) case. Our findings indicated good control of leprosy and a lower rate of dapsone resistance than that reported by the World Health Organization (4% vs. 13%) from 2009 to 2015. We found that the patient profile in terms of the treatment duration, recurrence rate, systemic symptoms, and neurological symptoms did not differ between before and during the pandemic. We report the recent advances in leprosy diagnosis, drug-resistant gene mutations, post-exposure prophylaxis, vaccination, and the effect of coronavirus disease 2019 on leprosy to facilitate updated leprosy diagnosis and management.<\/jats:p>","DOI":"10.3390\/diagnostics13243655","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T12:00:37Z","timestamp":1702468837000},"page":"3655","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and Treatment of Leprosy in Taiwan during the COVID-19 Pandemic: A Retrospective Study in a Tertiaty Center"],"prefix":"10.3390","volume":"13","author":[{"given":"Chin-Ling","family":"Hsieh","sequence":"first","affiliation":[{"name":"Department of Dermatology, MacKay Memorial Hospital, Taipei 10449, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pa-Fan","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, MacKay Memorial Hospital, Taipei 10449, Taiwan"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan"},{"name":"Department of Cosmetic Applications and Management, MacKay Medicine, Nursing and Management College, Taipei 11260, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization, and Organisation Mondiale de la Sant\u00e9 (2022). Global leprosy (Hansen disease) update, 2021: Moving towards interruption of transmission\u2014Situation de la l\u00e8pre (maladie de Hansen) dans le monde, 2021: Vers l\u2019interruption de la transmission. Wkly. Epidemiol. Rec., 97, 429\u2013450."},{"key":"ref_2","first-page":"133","article-title":"Epidemiology and Molecular Diagnosis of Leprosy, Taiwan, 2002\u20132016","volume":"33","author":"Huang","year":"2017","journal-title":"Epidemiol. Bull."},{"key":"ref_3","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int. J. Lepr. Other Mycobact. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Chaves, L.L., Patriota, Y., Soares-Sobrinho, J.L., Vieira, A.C.C., Lima, S.A.C., and Reis, S. (2020). Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication?. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121202"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Elaine Silva Nascimento Andrade, E.S.N., Brand\u00e3o, J.G., da Silva, J.S., Kurizky, P.S., Rosa, P.S., de Ara\u00fajo, W.N., and Gomes, C.M. (2021). A systematic review and meta-analysis of studies on the diagnostic accuracy and screening of tests to detect antimicrobial resistance in leprosy. Diagn. Microbiol. Infect. Dis., 100.","DOI":"10.1016\/j.diagmicrobio.2021.115325"},{"key":"ref_6","first-page":"e952","article-title":"Leprosy reactions after SARS-COV2 (COVID-19) infection","volume":"37","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","first-page":"618","article-title":"Molecular typing of Mycobacterium leprae strains from northern India using short tandem repeats","volume":"133","author":"Lavania","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"ref_8","first-page":"119","article-title":"A classification of leprosy for research purposes","volume":"33","author":"Ridley","year":"1962","journal-title":"Lepr. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cup.13425","article-title":"Lucio phenomenon mimicking antiphospholipid syndrome: The occurrence of antiphospholipid antibodies in a leprosy patient","volume":"46","author":"Guevara","year":"2019","journal-title":"J. Cutan. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/ds.ds_26_21","article-title":"Histoid leprosy complicated with Charcot neuroarthropathy: A case report","volume":"39","author":"Hsu","year":"2021","journal-title":"Dermatologica Sinica."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e971","DOI":"10.1111\/jdv.18390","article-title":"Reactions in leprosy patients triggered by COVID-19 vaccination\u2014A cross-sectional study from a tertiary care centre in India","volume":"36","author":"Bhandari","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1111\/jdv.18735","article-title":"Type 1 lepra reaction induced by a COVID-19 vaccine","volume":"37","author":"Hsu","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_13","first-page":"177","article-title":"Slit-skin smear in leprosy: Lest we forget it!","volume":"85","author":"Mahajan","year":"2013","journal-title":"Indian J. Lepr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2019.12.080","article-title":"Leprosy: Clinical aspects and diagnostic techniques","volume":"83","author":"Maymone","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/infdis\/162.1.193","article-title":"The use of a specific DNA probe and polymerase chain reaction for the detection of Mycobacterium leprae","volume":"162","author":"Williams","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Martinez, A.N., Talhari, C., Moraes, M.O., and Talhari, S. (2014). PCR-based techniques for leprosy diagnosis: From the laboratory to the clinic. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002655"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e20200197","DOI":"10.1590\/0037-8682-0197-2020","article-title":"Prospects for new leprosy diagnostic tools, a narrative review considering ELISA and PCR assays","volume":"53","author":"Gama","year":"2020","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/jcm.30.12.3095-3098.1992","article-title":"Effects of fixation on polymerase chain reaction detection of Mycobacterium leprae","volume":"30","author":"Fiallo","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4269\/ajtmh.13-0659","article-title":"Application of RLEP real-time PCR for detection of M. leprae DNA in paraffin-embedded skin biopsy specimens for diagnosis of paucibacillary leprosy","volume":"90","author":"Yan","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Torres, R.T., Fachi, M.M., B\u00f6ger, B., Marson, B.M., Ferreira, V.L., Pontarolo, R., and Guimar\u00e3es, T.M. (2021). Sensitivity and specificity of multibacillary and paucibacillary leprosy laboratory tests: A systematic review and meta-analysis. Diagn. Microbiol. Infect. Dis., 100.","DOI":"10.1016\/j.diagmicrobio.2021.115337"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Saar, M., Beissner, M., G\u00fcltekin, F., Maman, I., Herbinger, K.H., and Bretzel, G. (2021). RLEP LAMP for the laboratory confirmation of leprosy: Towards a point-of-care test. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06882-2"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.25259\/IJDVL_248_19","article-title":"Development of a novel loop-mediated isothermal amplification assay for rapid detection of Mycobacterium leprae in clinical samples","volume":"87","author":"Joshi","year":"2021","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"972244","DOI":"10.3389\/fmed.2022.972244","article-title":"Bacilloscopy and polymerase chain reaction of slit-skin smears and anti-phenolic glycolipid-I serology for Hansen\u2019s disease diagnosis","volume":"9","author":"Lima","year":"2022","journal-title":"Front. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Li, X., Li, G., Yang, J., Jin, G., Shao, Y., Li, Y., Wei, P., and Zhang, L. (2022). Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012443"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7883\/yoken.63.1","article-title":"Drug resistance in leprosy","volume":"63","author":"Matsuoka","year":"2010","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1590\/abd1806-4841.20176724","article-title":"Leprosy: Current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients","volume":"92","author":"Cruz","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.idnow.2022.04.001","article-title":"Drug resistance in leprosy: An update following 70years of chemotherapy","volume":"52","author":"Aubry","year":"2022","journal-title":"Infect. Dis. Now."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/ijd.15998","article-title":"Leprosy: What is new","volume":"61","author":"Randhawa","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_29","unstructured":"Cooreman, E.A. (2018). Guidelines for the Diagnosis, Treatment and Prevention of Leprosy."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/AAC.01212-10","article-title":"Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance","volume":"55","author":"Nakata","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.cmi.2018.02.022","article-title":"Antimicrobial resistance in leprosy: Results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15","volume":"24","author":"Cambau","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fimmu.2017.00233","article-title":"A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum","volume":"8","author":"Polycarpou","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1111\/jdv.17585","article-title":"Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: A prospective single-centre pilot study","volume":"35","author":"Narang","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.trstmh.2006.11.010","article-title":"Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions","volume":"101","author":"Marlowe","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamadermatol.2015.0384","article-title":"Minocycline for Recurrent and\/or Chronic Erythema Nodosum Leprosum","volume":"151","author":"Narang","year":"2015","journal-title":"JAMA Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e070922208607","DOI":"10.2174\/1871526522666220907125114","article-title":"Leprosy Reactions: Clinical Pharmacologist Perspective with Repurposed Medications","volume":"23","author":"Thangaraju","year":"2023","journal-title":"Infect. Disord. Drug Targets."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjd.18233","article-title":"Apremilast in chronic recalcitrant erythema nodosum leprosum: A report of two cases","volume":"182","author":"Narang","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.1111\/jdv.18339","article-title":"A spectrum of leprosy reactions triggered by COVID-19 vaccination: A series of four cases","volume":"36","author":"Saraswat","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/jdv.17915","article-title":"Trigger of Type 2 Lepra reaction with acute foot drop following COVID-19 vaccination","volume":"36","author":"Panda","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1111\/jdv.17761","article-title":"Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: A prospective cohort study in healthcare workers","volume":"36","author":"Rerknimitr","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/idoj.IDOJ_234_20","article-title":"Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by SIG Leprosy (IADVL Academy)","volume":"11","author":"Rathod","year":"2020","journal-title":"Indian Dermatol. Online J."},{"key":"ref_42","unstructured":"Pai, V.V., and Wakade, A. (2021, January 16\u201318). Leprosy and COVID-19 Co-infection\u2013Experience in a referral centre in Mumbai, India. Proceedings of the 31st Biennial Conference of Indian Association of Leprologists, Hyderabad, India."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cerqueira, S.R.P.S., Deps, P.D., Cunha, D.V., Bezerra, N.V.F., Barroso, D.H., Pinheiro, A.B.S., Pillegi, G.S., Repsold, T.A.R., Kurizky, P.S., and Collin, S.M. (2021). The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009635"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.4103\/idoj.idoj_513_21","article-title":"Updates on Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by IADVL SIG Leprosy","volume":"12","author":"Bhardwaj","year":"2021","journal-title":"Indian Dermatol. Online J."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Patra, J.K., Shukla, A.C., and Das, G. (2020). Advances in Pharmaceutical Biotechnology: Recent Progress and Future Applications, Springer.","DOI":"10.1007\/978-981-15-2195-9"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/RMHP.S76058","article-title":"Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy","volume":"9","author":"Duthie","year":"2016","journal-title":"Risk Manag. Healthc. Policy"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"104475","DOI":"10.1016\/j.micpath.2020.104475","article-title":"Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options","volume":"149","author":"Mungroo","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41541-018-0050-z","article-title":"LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection","volume":"3","author":"Duthie","year":"2018","journal-title":"Npj Vaccines"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/jinf.2000.0698","article-title":"Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: A systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy","volume":"41","author":"Smith","year":"2000","journal-title":"J. Infect."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","article-title":"Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: Cluster randomised controlled trial","volume":"336","author":"Moet","year":"2008","journal-title":"BMJ"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJMoa2205487","article-title":"Single-Dose Rifapentine in Household Contacts of Patients with Leprosy","volume":"388","author":"Wang","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMe2302667","article-title":"A New Step in Postexposure Prophylaxis for Leprosy","volume":"388","author":"Scollard","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/24\/3655\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:38:15Z","timestamp":1760132295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/24\/3655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":52,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["diagnostics13243655"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13243655","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2023,12,13]]}}}